U.S. Senate panel urges FTC to launch antitrust probe of Mylan

WASHINGTON, Nov 7 (Reuters) - The U.S. Senate Judiciary

Committee urged federal antitrust regulators on Monday to launch

a probe into whether EpiPen maker Mylan NV broke the law

by preventing schools from purchasing competing allergy

treatments.

Read more